Evidence map›Paper›PMID 32400915›Full record

ArticleAllergy2020

APPEAL-1: A multiple-country European survey assessing the psychosocial impact of peanut allergy.

Audrey DunnGalvin, Katharina Blumchen, Frans Timmermans, Lynne Regent, Sabine Schnadt, Marcia Podestà, Angel Sánchez, Pascale Couratier, Mary Feeney, Betina Hjorth and 6 more

Open access · hybridAbstract read
In one paragraph

Article in Allergy, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
5.6field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 57 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Review
  5. Article
  6. Selecting patients for food allergy therapy.Journal of food allergy · 2024
    Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Learning Early About Peanut worries: Evaluation of parental PROMIS-29 anxiety scores during early peanut introduction clinics.Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology · 2022
    Article
  17. Article
  18. Article
  19. S3 guideline Allergy Prevention.Allergologie select · 2022
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 8 institutions in 7 countries.

Audrey DunnGalvinSchool of Applied Psychology and Department of Paediatrics and Child Health, University College Cork, Cork, Ireland.ORCID 0000-0002-1540-3959
Katharina BlumchenDivision of Pneumology, Allergology and Cystic Fibrosis, Department of Children and Adolescent Medicine, University Hospital Frankfurt, Frankfurt am Main, Germany.
Frans TimmermansNederlands Anafylaxis Netwerk - European Anaphylaxis Taskforce, Dordrecht, The Netherlands.
Lynne RegentAnaphylaxis Campaign, Farnborough, UK.
Sabine SchnadtDeutscher Allergie- und Asthmabund (DAAB), Mönchengladbach, Germany.
Marcia PodestàFood Allergy Italia, Padua, Italy.
Angel SánchezAsociación Española de Personas con Alergia a Alimentos y Látex (AEPNAA), Madrid, Spain.
Pascale CouratierAssociation Française de Prévention des Allergies (AFPRAL), Paris, France.
Mary FeeneyDivision of Asthma, Allergy and Lung Biology, Department of Paediatric Allergy, King's College London, and Guy's and St. Thomas' NHS Foundation Trust, London, UK.
Betina HjorthAstma-Allergi Danmark, Roskilde, Denmark.
Ram PatelBrainsell Ltd., London, UK.
Tessa LushAimmune Therapeutics, London, UK.
Robert RyanAimmune Therapeutics, London, UK.ORCID 0000-0003-0827-3153
Andrea VeredaAimmune Therapeutics, London, UK.
Montserrat Fernández-RivasDepartment of Allergy, Hospital Clínico San Carlos, Universidad Complutense de Madrid, IdISSC, ARADyAL, Madrid, Spain.
Helen R FisherDivision of Asthma, Allergy and Lung Biology, Department of Paediatric Allergy, King's College London, and Guy's and St. Thomas' NHS Foundation Trust, London, UK.
Aimmune Therapeutics (United Kingdom) · GBKing's College London · GBAsociación Española de Urología · ESBioAxis DNA Research Centre (India) · INGoethe University Frankfurt · DERoskilde Sygehus · DKSechenov University · RUUniversidad Complutense de Madrid · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPeanut allergy (PA) is a common, potentially life-threatening and typically lifelong condition with a significant burden of illness. However, information is lacking on how persons with PA (PwPA) and their caregivers perceive the psychosocial impact of living with PA. The Allergy to Peanuts imPacting Emotions And Life 1 (APPEAL-1) survey, conducted across Europe, investigated the experience and impact of living with PA. Here, we report data evaluating the psychosocial impact of PA on PwPA and their caregivers.

methodsAllergy to Peanuts imPacting Emotions And Life study 1 was an online survey conducted in eight European countries. Representatives of eight patient advocacy groups and five healthcare-research specialists developed the survey. Eligible respondent groups included the following: adults diagnosed with PA (self-report); parent/nonparent caregivers (proxy-report for a child with PA); and parent/nonparent caregivers (self-report of PA impact on themselves).

resultsOf 1846 total study respondents, 419 were adults with PA (self-report); 546 were parents/caregivers (proxy-report); and 881 were parents/caregivers (self-report). Most respondents reported lifestyle restrictions regarding food (84%-93%) and additional domains including parties and socializing, holiday activities and destinations, and taking public transport (53%-89%). Approximately 40% rated themselves as "very" frustrated and "very" stressed. Two-thirds (65%) felt socially isolated; 43% were bullied. Less than half felt confident in knowing when to use an adrenaline autoinjector. Several intercountry differences were observed such as high levels of uncertainty and stress in respondents from Ireland, highest rates of anxiety in respondents from Germany, and social exclusion and isolation most common in respondents from France.

conclusionsPeanut allergy imposes an adverse psychosocial impact on patients and caregivers, leading to frustration, stress and isolation. Attention to the impact of PA is needed in research and clinical practice to improve PA healthcare and public education programmes.

Indexed as

Peanut HypersensitivityAdultChildEuropeFranceGermanyHumansIrelandSurveys and Questionnairesbullyingcopingdaily lifepeanut allergypsychosocial impacts

Identifiers

PMID32400915
PMCPMC7689848
OpenAlexW3024677421

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.